← Leaderboards
Young J. Kim
Johns Hopkins University
$4,039,490
Attributed
$4,746,837
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $641.4K · FY2008–23$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$4,746,837 · 5
By mechanism
R01$3,077,061 · 2
P50$936,456 · 2
K23$733,320 · 1
Top collaborators
- Sebastian Joyce3 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Steven R Kleeberger$929,417
- Dara L Kraitchman$14,405,090
- William Ramses Bishai$43,237,711
- Brian H. Ladle$1,546,152
- Arturo Casadevall$47,974,076
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsIn VivoCellsCancer PatientTumorBaseImmunotherapyMolecularImmuneNeoplastic CellVaccinesSpecimenCancer VaccinesImmunotherapeutic AgentCombinatorialPre-ClinicalResponseUnited States National Institutes Of HealthMissionCancer ImmunotherapyAgonistMalignant NeoplasmsCell TypeCancer Cell
Grant awards (19)
Immuno-Phenotyping Core$173,912
P50 · FY2023 · CA · contact PI
Immuno-Phenotyping Core$173,912
P50 · FY2022 · CA · contact PI
Immuno-Phenotyping Core$239,455
P50 · FY2021 · CA · contact PI
Head & Neck Cancer Neoantigen Characterization & Therapeutic Targeting$461,830
R01 · FY2020 · DE · contact PI
Immuno-Phenotyping Core$175,267
P50 · FY2020 · CA · contact PI
Head & Neck Cancer Neoantigen Characterization & Therapeutic Targeting$467,480
R01 · FY2019 · DE · contact PI
Immuno-Phenotyping Core$173,910
P50 · FY2019 · CA · contact PI
Head & Neck Cancer Neoantigen Characterization & Therapeutic Targeting$485,385
R01 · FY2018 · DE · contact PI
Cyclic Dinucleotides in Combinatorial Immunotherapy for Cancer$327,850
R01 · FY2017 · CA · contact PI
Cyclic Dinucleotides in Combinatorial Immunotherapy for Cancer$336,150
R01 · FY2016 · CA · contact PI
Cyclic Dinucleotides in Combinatorial Immunotherapy for Cancer$336,150
R01 · FY2015 · CA · contact PI
Cyclic Dinucleotides in Combinatorial Immunotherapy for Cancer$326,066
R01 · FY2014 · CA · contact PI
Cyclic Dinucleotides in Combinatorial Immunotherapy for Cancer$336,150
R01 · FY2013 · CA · contact PI
Combinational Immunoherapy of Head and Neck Squamous Cell Carcinoma$136,350
K23 · FY2012 · DE · contact PI
Combinational Immunoherapy of Head and Neck Squamous Cell Carcinoma$136,350
K23 · FY2011 · DE · contact PI
Combinational Immunoherapy of Head and Neck Squamous Cell Carcinoma$135,540
K23 · FY2010 · DE · contact PI
Combinational Immunoherapy of Head and Neck Squamous Cell Carcinoma$135,540
K23 · FY2009 · DE · contact PI
Combinational Immunoherapy of Head and Neck Squamous Cell Carcinoma$54,000
K23 · FY2009 · DE · contact PI
Combinational Immunoherapy of Head and Neck Squamous Cell Carcinoma$135,540
K23 · FY2008 · DE · contact PI